Wednesday, November 6 - Sunday, November 10
Drop by and meet our Precision team at booth #1122.
Chad Clark
President and Chief Operating Officer, Precision Medicine Group
Harpreet Singh, MD
Chief Medical Officer
Darren Davis, PhD
Senior Vice President
Matt Arnold
President, Translational Sciences
Steve Empoliti
Chief Commercial Officer
Amanda Woodrooffe, PhD
Senior Vice President, General Manager UK Labs
Find Precision for Medicine at booth #1122
George R. Brown Convention Center in Houston
Friday 8 November: 9:00AM – 7:00PM
Saturday 9 November: 9:00AM – 8:30PM
Contact us using the form below. Our team will reach out and set-up a meeting time while we are attending this year's SITC conference.
President and Chief Operating Officer, Precision Medicine Group
Recognized industry leader with deep expertise spanning biomarker-driven clinical development, patient access and global market access. In addition to the role at Precision Medicine Group, Chad is also President of Precision for Medicine. In prior roles he has served as Chief Operating Officer of United BioSource Corporation and founder of DataPhaseIV. Proven ability to scale operations in response to client needs, adding the end-to-end capabilities necessary to support development and patient access to today’s complex therapies.
Chief Medical Officer
Industry-leading oncologist and demonstrated medical leader in precision medicine, novel trial design and innovative regulatory initiatives designed to expedite drug approvals. Draws on nearly a decade leading oncology and rare disease programs at the FDA. Former fellow at the National Cancer Institute and frequent featured speaker at ASCO and AACR. CDER technical authority on oncologic drug and biological products for thoracic and head and neck malignancies, neurologic tumors, pediatric solid tumors and rare tumors.
Senior Vice President
Visionary leader with decades of distinguished biotechnology and clinical translational research experience. Founded ApoCell in 2004 and later was instrumental in developing and commercializing the ApoStream® rare-cell liquid biopsy technology. Globally recognized cancer researcher and the author of more than 100 peer-reviewed publications. Dedicated and committed to improving the lives of patients with debilitating diseases.
President, Translational Sciences
Strategic, highly collaborative biotechnology industry veteran, driven by opportunities to bring life-changing therapeutics to patients. Over two decades of global, cross-functional biotech and pharmaceutical experience, across both rapid growth and mature organizations, including leadership positions at AVROBIO, AstraZeneca, and Amgen.
Chief Commercial Officer
Visionary strategic leader, adept at propelling growth by strengthening relationships and enhancing capabilities to better meet customer needs. Driven by the desire to get advanced medicines to patients in need. Brings unique expertise from Fortune 100 companies, combining skills gleaned through commercial leadership, corporate strategy, client development, and global product management for major pharmaceutical companies, and more than a decade of management consulting to the life sciences industry.
Senior Vice President, General Manager UK Labs
Experienced leader of scientific operations for drug discovery in both the pharmaceutical and CRO industries. Driven to provide actionable data enabling biopharmaceutical research and development. Collaborative partner ensuring licensing and scientific support for corporate development initiatives.